Insider Trading History of Fiorino Anthony S.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Fiorino Anthony S. since 2014. The trader's CIK number is 1608901. At the time of the last reporting, Fiorino Anthony S. was the Chief Executive Officer of Immune Pharmaceuticals Inc. (stock ticker symbol IMNPQ). Also see all insider trading activities at Immune Pharmaceuticals Inc.

Note that in the past Fiorino Anthony S. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Immune Pharmaceuticals Inc (IMNPQ) by Fiorino Anthony S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 IMNPQ 0 $0 75,000 $300 0 $0
2018 IMNPQ 75,000 $18,875 0 $0 0 $0

Yearly summary of insider trading at Brainstorm Cell Therapeutics Inc. (BCLI) by Fiorino Anthony S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 BCLI 19,300 $9,986 0 $0 0 $0


Insider trading activities at 2 companies by Fiorino Anthony S.:

1. Immune Pharmaceuticals Inc (IMNPQ)

2. Brainstorm Cell Therapeutics Inc. (BCLI)

Table 1. Insider trading of Immune Pharmaceuticals Inc (IMNPQ) by Fiorino Anthony S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-03 IMNPQ Sale 75,000 .00 300
2018-05-22 IMNP Buy 25,000 .24 5,975
2018-05-17 IMNP Buy 50,000 .26 12,900

Table 2. Insider trading of Brainstorm Cell Therapeutics Inc. (BCLI) by Fiorino Anthony S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-10-15 BCLI Buy 500 3.60 1,797
2014-09-18 BCLI Buy 800 3.84 3,072
2014-09-12 BCLI Buy 10,000 .28 2,829
2014-09-15 BCLI Buy 8,000 .29 2,288

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fiorino Anthony S. (Chief Executive Officer of Immune Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.